Information about Bob Kiezebrink Research & Development
My details
*
*
*
{{translate('company_activity_bron_' + bron)}}
Code Description
{{activiteit.code}} {{activiteit.description}}

Bob Kiezebrink Research & Development (SRL)

Company information

Status
Active

KVK number

62468618

VAT Number

Established
22-01-2015
Last balance sheet year
2024
Company size
Micro 0 FTE
RSIN number
854830224
Principal activity
Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Bob Kiezebrink Research & Development

2024 2023 2022 2021
Equity -76 -100 % 73.394 -3 % 75.736 467 % 13.350
Employees 0 0 0 0

Frequently asked questions

What is the VAT number of Bob Kiezebrink Research & Development?
Log in or start a free trial to view the VAT number.
What is the KVK number of Bob Kiezebrink Research & Development?
The KVK number of Bob Kiezebrink Research & Development is 62468618
When was Bob Kiezebrink Research & Development founded?
Bob Kiezebrink Research & Development was founded on 22-01-2015.
What is the address of Bob Kiezebrink Research & Development?
The current registered office of Bob Kiezebrink Research & Development is located at Drieerweg 100/- 438, 3852 MB Ermelo.
When was the last time Bob Kiezebrink Research & Development filed their annual financial statements?
The most recent financial statements of Bob Kiezebrink Research & Development were filed on 21-08-2025.
How many employees does Bob Kiezebrink Research & Development have?
There are currently no employees working at Bob Kiezebrink Research & Development or no workforce information is available.
What is the annual turnover of Bob Kiezebrink Research & Development?
There is no turnover available for Bob Kiezebrink Research & Development.